Evid Invest
Who owns RDHLWhat RDHL owns — n/a

Who owns RedHill Biopharma Ltd.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of RDHL from SEC Form 13F filings across 14 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 14 institutions disclosed 315,818 shares of RedHill Biopharma Ltd. worth $270,048 — about 6.2% of shares outstanding; the largest disclosed holder is Yorkville Advisors Global, LP. Source: SEC Form 13F filings, parsed by EvidInvest.

14

13F holders

$270,048

value, 2026 filers

6.2%

of shares outstanding (315,818 sh)

2

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of RDHL's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Yorkville Advisors Global, LP122,131$106,6810.1%2.4%-65.2%
2GAGNON SECURITIES LLC88,405$74,7020.0%1.7%0.0%
3CITADEL ADVISORS LLC65,321$55,1960.0%1.3%+216.0%
4RHUMBLINE ADVISERS13,755$11,6200.0%0.3%+168.9%
5Lido Advisors, LLCNEW11,009$9,3030.0%0.2%new
6GAMMA Investing LLC6,957$5,8790.0%0.1%+4.1%
7CITIGROUP INCNEW4,378$3,6990.0%0.1%new
8Federation des caisses Desjardins du Quebec3,388$2,8630.0%0.1%0.0%
9ROYAL BANK OF CANADA351$00.0%0%+35000.0%
10UBS Group AG100$850.0%0%-87.9%
11SBI Securities Co., Ltd.15$130.0%0%+275.0%
12Smartleaf Asset Management LLC5$40.0%0%0.0%
13Vermillion Wealth Management, Inc.2$20.0%0%0.0%
14MORGAN STANLEY1$10.0%0%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.